Testing effectiveness (Phase 2)Study completedNCT01270321
What this trial is testing
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
Who this might be right for
Thyroid Cancer
Emory University 42